30 results
8-K
EX-1.1
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
Entity, against or affecting the Company relating to Hazardous Materials or any Environmental Laws.
(xxvi) Health Care Laws. Except where instances … as may be required by the FDA or any committee thereof, any other U.S. or foreign government drug or biological product regulatory agency, or health care facility
S-3
EX-1.2
6i95uu8h hie8m3r
1 Jul 22
Shelf registration
5:06pm
10-K
wt12f
28 Mar 22
Annual report
4:51pm
10-K
EX-10.7
cbgdmiwuxn
28 Mar 22
Annual report
4:51pm
10-K
EX-10.8
86crspotyhwaks
28 Mar 22
Annual report
4:51pm
10-K
EX-10.9
nfmbqyru67t bsh
28 Mar 22
Annual report
4:51pm
10-K
EX-10.10
3p5 bb3l0r2
28 Mar 22
Annual report
4:51pm
10-Q
a2bvm4gvlz1m3awp
16 Aug 21
Quarterly report
4:51pm
10-Q
EX-10.8
xpracs0qvouo4s
16 Aug 21
Quarterly report
4:51pm
424B4
3tpmb1 dof8a6l7kv5x4
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-1.1
3a4wcnq7fdk4b
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.1
gyv8szxdgksu 2znz9
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
8yxham xvlv7v17
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-10.9
9ajxsbf06pqbp fkz
9 Jun 21
IPO registration
5:02pm